The 10-year cumulative incidence of CBC estimates was higher for premenopausal than postmenopausal women carrying a P/LP variant in BRCA1 (33% vs. 12%), BRCA2 (27% vs. 9%), and CHEK2 (13% vs. 4%, respectively). This evidence concerns the gene BRCA2 and complete blood cell count.